Sign up to save your podcasts
Or
Share Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
7272 ratings
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.
CME information and select publications here.
More shows like Hematologic Oncology Update
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
495 Listeners
Breast Cancer Update
66 Listeners
Lung Cancer Update
31 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
115 Listeners
The Hematologist
27 Listeners
Mayo Clinic Talks
291 Listeners
The Curbsiders Internal Medicine Podcast
3,330 Listeners
The ONS Podcast
197 Listeners
Blood Podcast
54 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Blood Cancer Talks
49 Listeners
Two Onc Docs
189 Listeners
WolverHeme Happy Hour
30 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners